In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (Q81348007)
Jump to navigation
Jump to search
scientific article published on 24 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension |
scientific article published on 24 September 2007 |
Statements
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study (English)
Sverre E Kjeldsen
Peter M Okin
Katherine E Harris
Sverker Jern
Lars H Lindholm
Björn Dahlöf
LIFE Study Investigators
24 September 2007